Sun Pharma inks pact with LIB Therapeutics to sell LDL-C drug

Lerodalcibep is approved in the EU under the brand name Lyrokaul. In the U.S, it is FDA-approved under the brand name Lerochol
More news in Industry
ACME seals $3.6-billion deal for Odisha green ammonia project
Apollo Micro, Redon ink MoU to collaborate for tethered drone systems
Private LPG firm SHV Energy to invest ₹350-cr on expansion in five years
MEIL Group raises $700 million from global investors at ₹1 lakh crore valuation